Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
regenerativemedicine
Press Release
Jun 12, 2023
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 'Post Covid Syndrome'
Read More
Press Release
Dec 7, 2020
Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19
Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc. (Baylx) to co-sponsor and spearhead the clinical trial of Baylx's FDA approved IND for COVID-19 indication using Human Umbilical Cord Tissue Mesenchymal Stem Cells (hUC-MSC) product, as featured by BioInformant on November 23, 2020. This publication can be seen in full at https://bioinformant.com/invitrx-baylx-covid-19.
Read More
First
Prev
1
Next
Last
